PubMed

Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles.

Mudaliar S, Mohideen P, Deutsch R, Ciaraldi TP, Armstrong D, Kim B, Sha X, Henry RR.

Diabetes Care. 2002 Sep;25(9):1597-602.PMID: 12196433 [PubMed - indexed for MEDLINE]Related articlesFree article

Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion.

Scholtz HE, Pretorius SG, Wessels DH, Venter C, Potgieter MA, Becker RH.

Acta Diabetol. 2003 Dec;40(4):156-62.PMID: 14740274 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB.

Diabetes. 2000 Dec;49(12):2142-8.PMID: 11118018 [PubMed - indexed for MEDLINE]Related articlesFree article

Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjects.

Westerbacka J, Bergholm R, Tiikkainen M, Yki-Järvinen H.

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):320-4. Epub 2003 Dec 4.PMID: 14656737 [PubMed - indexed for MEDLINE]Related articlesFree article

Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine.

Dagogo-Jack S, Askari H, Morrill B, Lehner LL, Kim B, Sha X.

Diabetes Obes Metab. 2000 Dec;2(6):373-83.PMID: 11225967 [PubMed - indexed for MEDLINE]Related articles

Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.

Horvath K, Bock G, Regittnig W, Bodenlenz M, Wutte A, Plank J, Magnes C, Sinner F, Fürst-Recktenwald S, Theobald K, Pieber TR.

Diabetes Obes Metab. 2008 Jun;10(6):484-91. Epub 2007 Aug 30.PMID: 17764465 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique.

Scholtz HE, Pretorius SG, Wessels DH, Becker RH.

Diabetologia. 2005 Oct;48(10):1988-95. Epub 2005 Sep 14.PMID: 16160867 [PubMed - indexed for MEDLINE]Related articles

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.

Klein O, Lynge J, Endahl L, Damholt B, Nosek L, Heise T.

Diabetes Obes Metab. 2007 May;9(3):290-9.PMID: 17391154 [PubMed - indexed for MEDLINE]Related articles

Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.

Diabetes Care. 2006 Nov;29(11):2371-7.PMID: 17065670 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.

Kruszynska YT, Olefsky JM, Frias JP.

Metabolism. 2003 Feb;52(2):233-8.PMID: 12601639 [PubMed - indexed for MEDLINE]Related articles

Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

Diabetes. 2002 Oct;51(10):3043-8.PMID: 12351445 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR.

Diabetes Care. 1999 Sep;22(9):1501-6.PMID: 10480516 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

Porcellati F, Rossetti P, Busciantella NR, Marzotti S, Lucidi P, Luzio S, Owens DR, Bolli GB, Fanelli CG.

Diabetes Care. 2007 Oct;30(10):2447-52. Epub 2007 Jul 10. Erratum in: Diabetes Care. 2008 Jan;31(1):188. PMID: 17623819 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique.

Becker RH, Frick AD, Burger F, Scholtz H, Potgieter JH.

Exp Clin Endocrinol Diabetes. 2005 May;113(5):292-7. Erratum in: Exp Clin Endocrinol Diabetes. 2005 Jul;113(7):409. PMID: 15926116 [PubMed - indexed for MEDLINE]Related articles

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

Egan JM, Meneilly GS, Habener JF, Elahi D.

J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73.PMID: 12161508 [PubMed - indexed for MEDLINE]Related articlesFree article

A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

Plank J, Bodenlenz M, Sinner F, Magnes C, Görzer E, Regittnig W, Endahl LA, Draeger E, Zdravkovic M, Pieber TR.

Diabetes Care. 2005 May;28(5):1107-12.PMID: 15855574 [PubMed - indexed for MEDLINE]Related articlesFree article

Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.

Linn T, Fischer B, Soydan N, Eckhard M, Ehl J, Kunz C, Bretzel RG.

J Clin Endocrinol Metab. 2008 Oct;93(10):3839-46. Epub 2008 Jul 8.PMID: 18611975 [PubMed - indexed for MEDLINE]Related articlesFree article

In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man.

Gray RS, Scarlett JA, Griffin J, Olefsky JM, Kolterman OG.

Diabetes. 1982 Oct;31(10):929-36.PMID: 6759226 [PubMed - indexed for MEDLINE]Related articles

Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.

Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T.

Diabetes Care. 2000 Sep;23(9):1343-7.PMID: 10977030 [PubMed - indexed for MEDLINE]Related articlesFree article

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles